Inadequate antimicrobial treatment of infections: A risk factor for hospital mortality among critically III patients

Chest

Volumn 115, Issue 2, 1999, Pages 462-474

  Kollef, Marin H ^a,c   Sherman, Glenda ^b   Ward, Suzanne ^a   Fraser, Victoria J ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BJC HEALTHCARE   (United States)

^c Pulmonary and Critical Care Division   (United States)

Author keywords

Antibiotics; Bacteremia; Community acquired infection; Critical care; Infection; Nosocomial infection; Outcomes pneumonia

Indexed keywords

ANTACID AGENT; ANTIBIOTIC AGENT; CARBAPENEM; CEPHALOSPORIN DERIVATIVE; DALFOPRISTIN PLUS QUINUPRISTIN; HISTAMINE H2 RECEPTOR ANTAGONIST; HYPERTENSIVE AGENT; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SUCRALFATE; VANCOMYCIN;

ADULT; AGED; ANTIBIOTIC THERAPY; ARTICLE; BACTEREMIA; BACTERIAL PNEUMONIA; CRITICAL ILLNESS; FEMALE; HOSPITAL INFECTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PNEUMONIA; PRIORITY JOURNAL; RESPIRATORY TRACT INFECTION; RISK FACTOR; SEPTIC SHOCK; STRESS ULCER;

EID: 0032911760     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.115.2.462     Document Type: Article

References (48)

1. Mainardi JL, Carlet J, Acar J. Antibiotic resistance problems in the critical care unit. Crit Care Clinics 1998; 14:199-219
2. Gold HS, Moellering RC. Antimicrobial-drug resistance. N Engl J Med 1996; 335:1445-1453
3. Vincent JL, Bihari DJ, Suter PM, et al. The prevalence of nosocomial infection in intensive care units in Europe: results of the European Prevalence of Infection in Intensive Care (EPIC) Study; EPIC International Advisory Committee. JAMA 1995; 274:639-644
4. Fagon JY, Chastre J, Vuagnat A, et al. Nosocomial pneumonia and mortality among patients in intensive care units. JAMA 1996; 275:866-869
5. Brun-Buisson C, Doyon F, Carlet J, et al. Incidence, risk factors, and outcome of severe sepsis and septic shock in adults: a multicenter prospective study in intensive care units. JAMA 1995; 274:968-974
6. Herold BC, Immergluck LC, Maranan MC, et al. Community-acquired methicillin-resistant Staphylococcus aureus in children with no identified predisposing risk. JAMA 1998; 279:593-598
7. Livingston DH, Deitch EA. Multiple organ failure: a common problem in surgical intensive care unit patients. Ann Med 1995; 27:13-20
8. Kollef MH, Ward S. The influence of mini-BAL cultures on patient outcomes: implications for the antibiotic management of ventilator-associated pneumonia. Chest 1998; 113:412-420
9. Luna CM, Vujacich P, Niederman MS, et al. Impact of BAL data on the therapy and outcome of ventilator-associated pneumonia. Chest 1997; 111:676-685
10. Alvarez-Lerma F. Modification of empiric antibiotic treatment in patients with pneumonia acquired in the intensive care unit. ICU-Acquired Pneumonia Study Group. Intensive Care Med 1996; 22:387-394
11. Rello J, Gallego M, Mariscal D, et al. The value of routine microbial investigation in ventilator-associated pneumonia. Am J Respir Crit Care Med 1997; 156:196-200
12. Montravers P, Gauzit R, Muller C, et al. Emergence of antibiotic-resistant bacteria in cases of peritonitis after intra-abdominal surgery affects the efficacy of empirical antimicrobial therapy. Clin Infect Dis 1996; 23:486-494
13. Chow JW, Fine DM, Shlaes DM, et al. Enterobacter bacteremia: clinical features and emergence of antibiotic resistance during therapy. Ann Intern Med 1991; 115:585-590
14. Romero-Vivas J, Rubio M, Fernandez C, et al. Mortality associated with nosocomial bacteremia due to methicillin-resistant Staphylococcus aureus. Clin Infect Dis 1995; 21: 1417-1423
15. Chang VC, Huang CC, Wang ST, et al. Risk factor of complications requiring neurosurgical intervention in infants with bacterial meningitis. Pediatr Neurology 1997; 17:144-149
16. Heath CH, Grove DI, Looke DF. Delay in appropriate therapy of Legionella pneumonia associated with increased mortality. Euro J Clin Microbiol Infect Dis 1996; 15:286-290
17. Bartlett JG, Breiman RF, Mandell LA, et al. Community-acquired pneumonia in adults-guidelines for management. Clin Infect Dis 1998; 26:811-838
18. Campbell GD, Niederman MS, Broughton WA, et al. Hospital-acquired pneumonia in adults: diagnosis, assessment of severity, initial antimicrobial therapy, and preventive strategies. A consensus statement. Am J Respir Crit Care Med 1996; 153:1711-1725
19. Goldman DA, Weinstein RA, Wenzel RP, et al. Strategies to prevent and control the emergence and spread of antimicrobial-resistant microorganisms in hospitals: a challenge to hospital leadership. JAMA 1996; 275:234-240
20. Knaus WA, Wagner DP, Draper EA, et al. The APACHE III prognostic system: risk prediction of hospital mortality for critically ill hospitalized adults. Chest 1991; 100:1619-1636
21. Pingleton SK, Fagon JY, Leeper KV Jr. Patient selection for clinical investigation of ventilator-associated pneumonia: criteria for evaluating diagnostic techniques. Chest 1992; 102: 553S-556S
22. Garner JS, Jarvis WR, Emori TB, et al. CDC definitions for nosocomial infections. Am J Infect Control 1988; 16:128-140
23. Rubin DB, Wiener-Kronish JP, Murray JF, et al. Elevated von Willebrand factor antigen is an early phase predictor of acute lung injury in nonpulmonary sepsis syndrome. J Clin Invest 1990; 86:474-480
24. American College of Chest Physicians/Society of Crit Care Med Consensus Conference. Definitions for sepsis and multiple organ failure and guidelines for the use of innovative therapies in sepsis. Chest 1992; 101:1644-1655
25. Meinert CL, Tonascia S. Clinical trials: design, conduct, and analysis. New York, NY: Oxford University Press, 1986;194-195
26. SAS/STAT User's Guide (Vol. 2). Cary, NC: SAS Institute. 1990:1071-1126
27. Concato J, Feinstein AR, Holford TR. The risk of determining risk with multivariable models. Ann Intern Med 1993; 118:201-210
28. Rothman KJ. Analysis of crude data. In: Rothman K, ed. Modern Epidemiology. Boston, MA: Little Brown, 1986; 153-174
29. Celis R, Torres A, Gatell JM, et al. Nosocomial pneumonia: a multivariate analysis of risk and prognosis. Chest 1988; 93:318-324
30. Torres A, Aznar R, Gatell JM, et al. Incidence, risk, and prognosis factors of nosocomial pneumonia in mechanically ventilated patients. Am Rev Respir Dis 1990; 142:523-528
31. Fagon JY, Chastre J, Hance AJ, et al. Nosocomial pneumonia in ventilated patients: a cohort study evaluating attributable mortality and hospital stay. Am J Med 1993; 94:281-288
32. Kollef MH, Silver P, Murphy DM, et al. The effect of late-onset ventilator-associated pneumonia in determining patient mortality. Chest 1995; 108:1655-1662
33. Rello J, Ausina V, Ricart M, et al. Impact of previous antimicrobial therapy on the etiology and outcome of ventilator-associated pneumonia. Chest 1993; 104:1230-1235
34. Trovillet JL, Chastre J, Vuagnat A, et al. Ventilator-associated pneumonia caused by potentially drug-resistant bacteria. Am J Respir Crit Care Med 1998; 157:531-539
35. Rello J, Ausina V, Ricart M, et al. Risk factors for infection by Pseudomonas aeruginosa in patients with ventilator-associated pneumonia. Intensive Care Med 1994; 20:193-198
36. Baraibar J, Correa H, Mariscal D, et al. Risk factors for infection by Acinetobacter baumanii in intubated patients with nosocomial pneumonia. Chest 1997; 112:1050-1054
37. Kollef MH, Sharpless L, Vlasnik J, et al. The impact of nosocomial infections on patient outcomes following cardiac surgery. Chest 1997; 112:666-675
38. Brun-Buisson C, Doyon F, Carlet J, et al. Bacteremia and severe sepsis in adults: a multicenter prospective survey in ICUs and wards of 24 hospitals. The French Bacteremia-Sepsis Study Group. Am J Respir Crit Care Med 1996; 154:617-624
39. Weinstein MP, Towns ML, Quartey SM, et al. The clinical significance of positive blood cultures in the 1990s: a prospective comprehensive evaluation of the microbiology, epidemiology, and outcome of bacteremia and fungemia in adults. Clin Infect Dis 1997; 24:584-602
40. Valles J, Leon C, Alvarez-Lerma F. Nosocomial bacteremia in critically ill patients: a multicenter study evaluating epidemiology and prognosis. Clin Infect Dis 1997; 24:387-395
41. Vidal F, Mensa J, Almela M, et al. Epidemiology and outcome of Pseudomonas aeruginosa bacteremia, with special emphasis on the influence of antibiotic treatment: analysis of 189 episodes. Arch Intern Med 1996; 156:2121-2126
42. O'Grady NP, Barie PS, Bartlett J, et al. Practice parameters for evaluating new fever in critically ill adult patients. Task Force of the American College of Critical Care Medicine of the Society of Critical Care Medicine in Collaboration with the Infectious Disease Society of America. Crit Care Med 1998; 26:392-408
43. Pestotnik SL, Classen DC, Evans RS, et al. Implementing antibiotic practice guidelines through computer-assisted decision support: clinical and financial outcomes. Ann Intern Med 1996; 124:884-890
44. Evans RS, Pestotnik SL, Classen DC, et al. A computer-assisted management program for antibiotics and other anti-infective agents. N Engl J Med 1998; 338:232-238
45. Bergogne-Berezin E. Treatment and prevention of nosocomial pneumonia. Chest 1995; 108:26S-34S
46. Kollef MH, Eisenberg PR, Ohlendorf MF, et al. The accuracy of elevated concentrations of endotoxin in bronchoalveolar lavage fluid for the rapid diagnosis of Gram-negative pneumonia. Am J Respir Crit Care Med 1996; 154:1020-1028
47. McCabe KM, Khan G, Zhang YH, et al. Amplification of bacterial DNA using highly conserved sequences: automated analysis and potential for molecular triage of sepsis. Pediatrics 1995; 95:165-169
48. Burgener-Kairuz P, Zuber JP, Jaunin P, et al. Rapid detection and identification of Candida albicans and Torulopsis (Candida) glabrata in clinical specimens by species-specific nested PCR amplification of a cytochrome P-450 lanosterol-alpha-demethylase (L1A1) gene fragment. J Clin Microbiol 1994; 32:1902-1907